We have located links that may give you full text access.
[Effects of an obesogenic diet enriched in sardine by-products on pro-atherogenic markers in Wistar rats].
Annales de Cardiologie et D'angéiologie 2016 June
AIM OF THE STUDY: The effects of an obesogenic diet enriched in sardine by-products (Sardina pilchardus) on blood pressure, glycemic control and some cardiovascular risk factors, in particular pro-atherogenic were studied on an experimental model.
MATERIALS AND METHODS: Male rats (n=12) weighing 200±10g were subjected to an adjustment phase of 10 days in an obesogenic diet containing 30% sheep fat. After this period, the rats were divided into two homogeneous groups. The first group (HF-SBp) consumes the obesogenic diet supplemented with 30% of by-products flour (F-SBp), and the second (HF) continuous to consume the obesogenic diet and serve as control.
RESULTS: At day 30, in HF-SBp versus HF group: a reduction was noted in diastolic (-11%) and systolic (-10%) pressure, glycemia (-19%), glycated hemoglobin percent (-43%), serum total lipids concentration (-22%), triacylglycerols (-37%), total cholesterol (-29%) and unesterified cholesterol (-30%), cholesteryl esters (-30%), cholesterol of very low density lipoprotein (-37%) and low density (-37%) was noted. Inversely, high-density lipoprotein cholesterol and LCAT activity were enhanced by 19% and 77%, respectively. However, the atherogenicity index and membrane fluidity were reduced (P<0.05).
CONCLUSION: Sardine by-products probably by their bioactive compounds properties seem to have antihypertensive, antidiabetic, hypolipidemic and antiatherogenic properties that could prevent and/or attenuate some metabolic disorders associated with obesity.
MATERIALS AND METHODS: Male rats (n=12) weighing 200±10g were subjected to an adjustment phase of 10 days in an obesogenic diet containing 30% sheep fat. After this period, the rats were divided into two homogeneous groups. The first group (HF-SBp) consumes the obesogenic diet supplemented with 30% of by-products flour (F-SBp), and the second (HF) continuous to consume the obesogenic diet and serve as control.
RESULTS: At day 30, in HF-SBp versus HF group: a reduction was noted in diastolic (-11%) and systolic (-10%) pressure, glycemia (-19%), glycated hemoglobin percent (-43%), serum total lipids concentration (-22%), triacylglycerols (-37%), total cholesterol (-29%) and unesterified cholesterol (-30%), cholesteryl esters (-30%), cholesterol of very low density lipoprotein (-37%) and low density (-37%) was noted. Inversely, high-density lipoprotein cholesterol and LCAT activity were enhanced by 19% and 77%, respectively. However, the atherogenicity index and membrane fluidity were reduced (P<0.05).
CONCLUSION: Sardine by-products probably by their bioactive compounds properties seem to have antihypertensive, antidiabetic, hypolipidemic and antiatherogenic properties that could prevent and/or attenuate some metabolic disorders associated with obesity.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app